Author: admin

  • Stephen Timms – 2016 Parliamentary Question to the Department of Health

    Stephen Timms – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Stephen Timms on 2016-04-22.

    To ask the Secretary of State for Health, pursuant to the Answer of 19 April 2016 to Question 33687, what new investment which is in line with the Collaborative TB Strategy for England has been made to deliver (a) TB awareness raising, (b) TB case finding and screening and (c) treatment for (i) homeless people and (ii) other under-served sectors of the population.

    Jane Ellison

    Public Health England has resourced a National Tuberculosis (TB) Office to support implementation of the Collaborative TB Strategy for England, including working with stakeholders on awareness raising and case finding and treatment. The National TB Office is also overseeing the work of a Task and Finish group, which is looking at how to tackle the needs of those with TB in under-served populations, including homeless people. The group will present their findings to the National TB Programme in the autumn. Currently, however, there is no new investment being specifically targeted at the homeless population.

    NHS England has provided new investment, £10 million in 2015/16 and a further £10 million for 2016/17, to support latent TB infection testing and treatment which includes funding for TB awareness raising and TB case finding and treatment. The latter service is of particular relevance to the homeless population.

  • Louise Haigh – 2016 Parliamentary Question to the Department of Health

    Louise Haigh – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Louise Haigh on 2016-04-22.

    To ask the Secretary of State for Health, what discussions he has had with (a) the Nursing and Midwifery Council, (b) the Royal College of Midwives, (c) the Royal College of Nursing and (d) Independent Midwives UK on changes to midwifery regulation.

    Ben Gummer

    The Nursing and Midwifery Council (NMC), the Royal College of Midwives (RCM) and Independent Midwives UK (IMUK) have all been involved in discussions concerning the proposed changes to midwifery regulation.

    On 22 January 2016 the Department, on behalf of the four United Kingdom Chief Nursing Officers and their external partners, published plans for a new non-statutory system of midwifery supervision that will meet the need for clinical supervision of midwives in clinical practice, and peer review for those not in clinical practice. The NMC, RCM and IMUK were consulted on and contributed to the published proposals.

    The Royal College of Nursing has not been involved in the above discussions, as midwifery regulations do not affect nurses.

  • Stephen Timms – 2016 Parliamentary Question to the Department of Health

    Stephen Timms – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Stephen Timms on 2016-04-22.

    To ask the Secretary of State for Health, pursuant to the Answer of 19 April 2016 to Question 33687, what funding and support (a) his Department and (b) NHS England have provided to integrate blood-borne virus testing into mobile digital radiology screening for active TB in line with NICE guidance NG33 of January 2016.

    Jane Ellison

    As yet, no funding has been allocated to include blood-borne virus (BBV) testing into mobile screening outreach services.

    NHS England has provided additional funding to the London ‘Find & Treat’ mobile health unit so that they can offer latent Tuberculosis testing and treatment. The Find & Treat service continues its discussions with the Hepatitis C Trust to work in partnership to provide on-the-spot screening for hepatitis C and onward care.

    The National Institute for Health and Care Excellence guidance NG33 published in January 2016 suggests that integrating BBV testing into mobile digital radiology screening services would be good practice. NHS England has expressed an interest to consider this further, and discussions continue with the lead London Clinical Commissioning Groups.

  • Barry Sheerman – 2016 Parliamentary Question to the Department of Health

    Barry Sheerman – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Barry Sheerman on 2016-04-22.

    To ask the Secretary of State for Health, how much was paid in prescription charges in England and Wales in 2015-16.

    Alistair Burt

    We do not have an audited figure for the total amount paid in prescription charges in England in the community for 2015-16. However, provisional data for this 2015-16 financial year indicates that, up to the end of February 2016, £402.7 million was paid. An additional £124.4 million was also paid up to the end of March 2016 through the purchase of prescription prepayment certificates (PPCs). For 2014-15, which is the latest year for which we have an audited figure, revenue from prescriptions charges dispensed in the community, including PPC revenue, totalled £503.9 million. Approximately 90% of prescriptions are dispensed in England without charge.

    Prescription charges were abolished in Wales in 2007, and the Department does not have data on prescription charges collected in Wales for prescriptions issued in England.

  • Craig Williams – 2016 Parliamentary Question to the Department of Health

    Craig Williams – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Craig Williams on 2016-04-22.

    To ask the Secretary of State for Health, what his policy is on how the Government plans to transpose the provisions of the EU Tobacco Products Directive on restrictions on e-cigarette advertising into UK law to take account of Public Health England’s conclusions on the level of harm e-cigarettes cause relative to smoking.

    Jane Ellison

    The Government recognises that electronic cigarettes (e-cigarettes) help smokers quit and the evidence indicates that they are considerably less harmful to health than cigarettes. At the same time, it is essential that we do not encourage smoking and that we continue to protect children from the dangers of nicotine. For this reason, the Department welcomes the new rules set out in the revised Tobacco Products Directive (TPD) which will apply in the United Kingdom from 20 May 2016.

    The Government has taken a minimal approach to transposition of the TPD provisions on e-cigarette advertising into UK law, taking into account existing European case law. The Directive requires a prohibition of e-cigarette advertising in certain media such as TV and newspapers and online, but not for example on billboards. The provisions are compatible with the right to an individual’s freedom of speech and do not prevent individuals’ independent reviews on social media or internet forums. These provisions are enacted by The Tobacco and Related Products Regulations 2016/507 and changes to the Office of Communications Broadcast Codes.

    The Department will work in close partnership with the Advertising Standards Authority and Trading Standards, including on the need for further guidance for businesses, especially in the first year of implementation to build compliance with the new requirements.

  • Liz McInnes – 2016 Parliamentary Question to the Department of Health

    Liz McInnes – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Liz McInnes on 2016-04-22.

    To ask the Secretary of State for Health, what steps his Department is taking to help reduce the number of hospitals which do not have a multi-disciplinary diabetes foot care team as advised in NICE guidance.

    Jane Ellison

    The National Institute for Health and Care Excellence (NICE) has published clinical guidance and quality standards on the treatment of diabetes and its complications. The NICE Diabetes Quality Standard is clear that people with diabetes who are at risk of foot ulceration should receive regular reviews by a foot protection team in accordance with its clinical guidance. The Health and Social Care Act (2012) places a duty on NHS England to have regard to the NICE Quality Standards. Clinical commissioning groups should also have regard to them in planning and delivering services, as part of a general duty to secure a continuous improvement in quality.

    Our mandate to NHS England for next year includes an objective for NHS England “to lead a step change in the NHS in preventing ill health and supporting people to live healthier lives”.

    There has been an increase in the provision of access to a Multidisciplinary Diabetes Foot care Teams and an indicator measuring performance is included within the National Diabetes Audit to enable progress to be tracked. The focus to date has been on improving access to assessment and treatment by a specialist team. In terms of the proportion of hospitals with a Multidisciplinary Diabetes Foot Care Team, this was 60% in 2011, 72% in 2013, and the figure for 2015 will be published soon as part of the National Diabetes Inpatient Audit 2015 report.

  • Craig Williams – 2016 Parliamentary Question to the Department of Health

    Craig Williams – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Craig Williams on 2016-04-22.

    To ask the Secretary of State for Health, if his Department will provide guidance on what communications by e-cigarette manufacturers will fall to be considered as (a) informative and (b) promotional under the provision of the Tobacco Products Directive.

    Jane Ellison

    The Government recognises that electronic cigarettes (e-cigarettes) help smokers quit and the evidence indicates that they are considerably less harmful to health than cigarettes. At the same time, it is essential that we do not encourage smoking and that we continue to protect children from the dangers of nicotine. For this reason, the Department welcomes the new rules set out in the revised Tobacco Products Directive (TPD) which will apply in the United Kingdom from 20 May 2016.

    The Government has taken a minimal approach to transposition of the TPD provisions on e-cigarette advertising into UK law, taking into account existing European case law. The Directive requires a prohibition of e-cigarette advertising in certain media such as TV and newspapers and online, but not for example on billboards. The provisions are compatible with the right to an individual’s freedom of speech and do not prevent individuals’ independent reviews on social media or internet forums. These provisions are enacted by The Tobacco and Related Products Regulations 2016/507 and changes to the Office of Communications Broadcast Codes.

    The Department will work in close partnership with the Advertising Standards Authority and Trading Standards, including on the need for further guidance for businesses, especially in the first year of implementation to build compliance with the new requirements.

  • Barry Sheerman – 2016 Parliamentary Question to the Department of Health

    Barry Sheerman – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Barry Sheerman on 2016-04-22.

    To ask the Secretary of State for Health, if he will estimate the potential annual cost to the public purse of exempting all people with long-term medical conditions from prescription charges.

    Alistair Burt

    We have not made a recent estimate of the cost to the public purse in lost revenue from introducing an exemption from prescription charges for all people with long-term medical conditions. However, the review of prescription charges by Professor Sir Ian Gilmore, which was commissioned by a previous Government and published in 2010, estimated that extending the prescription charge exemption to everyone with a long-term condition would cost £360 to £430 million a year. This is likely to be an underestimate, given the increase in the prescription charge and increasing numbers of prescriptions dispensed since the Review was published. Overall prescription charge revenue for 2014/15, which is the last year for which we have a complete audited figure, was £503.9 million.

    A number of prescription charge exemptions are in place, for which someone with a long-term condition may qualify. These include exemptions based on low income, such as certain out of work benefits and the NHS Low Income Scheme, and age. Where someone does not qualify for exemption, Prescription Prepayment Certificates are available. The 3-month and 12-month certificates allow someone to claim as many prescriptions as they need for £29.10 and £104, respectively. Approximately 90% of all prescriptions are dispensed in England without a charge.

  • Craig Williams – 2016 Parliamentary Question to the Department of Health

    Craig Williams – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Craig Williams on 2016-04-22.

    To ask the Secretary of State for Health, what guidance his Department plans to provide on types of e-cigarette advertising which will be permitted following the introduction of restrictions under the EU Tobacco Product Directive on 20 May 2016.

    Jane Ellison

    The Government recognises that electronic cigarettes (e-cigarettes) help smokers quit and the evidence indicates that they are considerably less harmful to health than cigarettes. At the same time, it is essential that we do not encourage smoking and that we continue to protect children from the dangers of nicotine. For this reason, the Department welcomes the new rules set out in the revised Tobacco Products Directive (TPD) which will apply in the United Kingdom from 20 May 2016.

    The Government has taken a minimal approach to transposition of the TPD provisions on e-cigarette advertising into UK law, taking into account existing European case law. The Directive requires a prohibition of e-cigarette advertising in certain media such as TV and newspapers and online, but not for example on billboards. The provisions are compatible with the right to an individual’s freedom of speech and do not prevent individuals’ independent reviews on social media or internet forums. These provisions are enacted by The Tobacco and Related Products Regulations 2016/507 and changes to the Office of Communications Broadcast Codes.

    The Department will work in close partnership with the Advertising Standards Authority and Trading Standards, including on the need for further guidance for businesses, especially in the first year of implementation to build compliance with the new requirements.

  • Steve Rotheram – 2016 Parliamentary Question to the Department of Health

    Steve Rotheram – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Steve Rotheram on 2016-04-22.

    To ask the Secretary of State for Health, what steps his Department has taken to support research into mesothelioma.

    George Freeman

    The Government agrees that more mesothelioma research is needed and has taken measures to stimulate an increase in the level of research activity.

    Patients, carers, clinicians and funders have worked in partnership to identify what the priorities in research are. Following a survey and a workshop, the top 10 mesothelioma research priorities were announced in December 2014. The National Institute for Health Research (NIHR) published a final report from the Priority Setting Partnership in July 2015. In advance of the identification of research questions by this partnership, the NIHR highlighted to the research community that it wanted to encourage research applications in mesothelioma.

    The NIHR subsequently invited researchers to apply for mesothelioma research funding, in particular to address the research questions identified through the partnership. Eight NIHR programmes participated in this themed call. Fifteen individual applications were received, of which two have been approved for funding.

    In addition, the NIHR Research Design Service continues to be able to help prospective applicants develop competitive research proposals. This service is well-established and has

    10 regional bases across England. It supports researchers to develop and design high-quality proposals for submission to NIHR itself and also to other national, peer-reviewed funding competitions for applied health or social care research.

    The National Cancer Research Institute is facilitating ongoing dialogue between relevant research funders on the topic of mesothelioma, to discuss what the barriers to research are and what is needed to stimulate research in the field.

    The Chancellor’s Budget Report committed £5 million of LIBOR fines over the next four years for the National Mesothelioma Centre.

    The Department has received recent representations relating to funding of mesothelioma research from the Asbestos Victims Support Groups’ Forum UK and from several hon. Members on behalf of constituents.